← All companies

PULM

Pulmatrix, Inc.

PULM Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.74

+0.04 +2.35%

Key statistics

from XBRL data in SEC filings

Market cap

$6.35M

Revenue (TTM)

$7.81M

Net income (TTM)

-$4.53M

EPS (TTM)

$-1.23

P/E ratio

—

Dividend yield

—

Free cash flow

-$5.83M

Cash

$3.32M

Total assets

$4.50M

Gross margin

—

52-week range

$1.16 – $5.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K/A Fiscal year ended 2025-12-31 Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Regulation FD disclosure; Other events Apr 21, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Change in control; Amended charter or bylaws; Regulation FD disclosure Mar 27, 2026 8-K Terminated a material agreement; Regulation FD disclosure Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure; Other events Dec 18, 2025 10-Q Quarter ended 2025-09-30 Oct 16, 2025 8-K Results of operations (earnings release) Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results; Other events Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Completed an acquisition or disposition May 15, 2025 8-K Entered a material agreement; Change in control Apr 10, 2025 8-K Shareholder vote results Apr 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Results of operations (earnings release) Mar 21, 2025 8-K Amended charter or bylaws Feb 14, 2025 8-K Shareholder vote results Dec 20, 2024 8-K Entered a material agreement; Change in control; Director or officer change; Regulation FD disclosure Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 8, 2024 8-K Item 5.08 Oct 8, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Jul 19, 2024 8-K Entered a material agreement; Other events May 29, 2024 8-K Regulation FD disclosure May 15, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 10, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Director or officer change Mar 13, 2024 8-K Regulation FD disclosure Mar 4, 2024 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023